# OnCo record io102-io103 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/io102-io103/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "io102-io103" ;
  schema:name "IO102-IO103"@en ;
  schema:description "IO102-IO103 is an experimental peptide (immunotherapeutic vaccine) from IO Biotech in phase 3 trials for melanoma and head and neck squamous cell carcinoma, aimed at PD-L1."@en ;
  schema:url <https://onco.cc/drugs/io102-io103/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=IO102> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "peptide (immunotherapeutic vaccine)" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/ido1/> ;
  onco:companies <https://onco.cc/companies/io-biotech/> ;
  onco:trials <https://onco.cc/trials/nct05155254/>, <https://onco.cc/trials/nct05280314/> .